Abstract
Novel perylenebisimide-based fluorescent chemosensors PBI-5 and PBI-6 were designed and synthesized. Their selective recognition behavior toward metal ions was investigated by visual colorimetry and fluorescence spectroscopy. PBI-5 successfully exhibits a fluorescence turn-on response for Zn2+ and switch-off response for Cu2+ in neutral buffer solution, but the fluorescence turn-on response is moderately perturbed by Cd2+ and Pb2+. PBI-6 can effectively eliminate or weaken Pb2+ and Cd2+ induced interference and shows a better selectivity for Zn2+. Live cell imaging experiments indicates that both PBI-5 and PBI-6 can successfully enter the cell and apply in cell fluorescence imaging.
Keywords: Cell fluorescence imaging, colorimetry assay, fluorescent chemosensor, perylenebisimide, photoinduced electron transfer, selective recognition, retardation, magnesium, copper, iron, calcium
Letters in Organic Chemistry
Title:Perylenebisimide-based Fluorescent Chemosensors for Selective Detection of Zn2+ in Aqueous Solution
Volume: 9 Issue: 7
Author(s): Xuefeng Cong, Ningjie Wu, Lei Ma, Mingliang Li, Rongqi Zhou, Ge Gao and Jingbo Lan
Affiliation:
Keywords: Cell fluorescence imaging, colorimetry assay, fluorescent chemosensor, perylenebisimide, photoinduced electron transfer, selective recognition, retardation, magnesium, copper, iron, calcium
Abstract: Novel perylenebisimide-based fluorescent chemosensors PBI-5 and PBI-6 were designed and synthesized. Their selective recognition behavior toward metal ions was investigated by visual colorimetry and fluorescence spectroscopy. PBI-5 successfully exhibits a fluorescence turn-on response for Zn2+ and switch-off response for Cu2+ in neutral buffer solution, but the fluorescence turn-on response is moderately perturbed by Cd2+ and Pb2+. PBI-6 can effectively eliminate or weaken Pb2+ and Cd2+ induced interference and shows a better selectivity for Zn2+. Live cell imaging experiments indicates that both PBI-5 and PBI-6 can successfully enter the cell and apply in cell fluorescence imaging.
Export Options
About this article
Cite this article as:
Cong Xuefeng, Wu Ningjie, Ma Lei, Li Mingliang, Zhou Rongqi, Gao Ge and Lan Jingbo, Perylenebisimide-based Fluorescent Chemosensors for Selective Detection of Zn2+ in Aqueous Solution, Letters in Organic Chemistry 2012; 9 (7) . https://dx.doi.org/10.2174/157017812802139663
DOI https://dx.doi.org/10.2174/157017812802139663 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toxicity of Carbon Nanotubes
Current Drug Metabolism Repetitive Transcranial Magnetic Stimulation for ALS
CNS & Neurological Disorders - Drug Targets Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation
Current Pharmaceutical Design Voltage-Gated Sodium Channel Blockers: Synthesis of Mexiletine Analogues and Homologues
Current Medicinal Chemistry Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
Current Topics in Medicinal Chemistry Copper Compounds in Anticancer Strategies
Current Medicinal Chemistry How Would Composite Traditional Chinese Medicine Protect the Brain – An Example of the Composite Formula “Pien Tze Huang”
Current Medicinal Chemistry Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Aggresome Formation and Neurodegenerative Diseases: Therapeutic Implications
Current Medicinal Chemistry Synthesis and Evaluation of 2-benzylidene-1-tetralone Derivatives for Monoamine Oxidase Inhibitory Activity
Central Nervous System Agents in Medicinal Chemistry Mitochondrial-Associated Metabolic Changes and Neurodegeneration in Huntingtons Disease - from Clinical Features to the Bench
Current Drug Targets Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State
Current Pharmaceutical Design Neurological Disorders in Medical Use of <i>Cannabis</i>: An Update
CNS & Neurological Disorders - Drug Targets Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis
Drug Metabolism Letters Editorial [The Multifactorial Nature of Alzheimers Disease and Related Therapeutic Strategies (Executive Editors: Maria do Carmo Carreiras and Jose Marco-Contelles)]
Current Pharmaceutical Design Glutamate-Mediated Signaling and Autism Spectrum Disorders: Emerging Treatment Targets
Current Pharmaceutical Design The GLUTs Family - Lessons from Transgenic Mice
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Metabotropic Glutamate Receptors as Drug Targets
Current Drug Targets Parkinson’s Disease and Alpha-Synucleinopathies: from Arising Pathways to Therapeutic Challenge
Central Nervous System Agents in Medicinal Chemistry Neurofilament Proteins as Prognostic Biomarkers in Neurological Disorders
Current Pharmaceutical Design